Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Beijing Konruns Pharmaceutical Co Ltd
603590Current price
24.38 CNY
-0.77 CNY (-3.06%)
Last closed
25.07 CNY
Company
www.konruns.cn
ISIN
CNE1000036K3
Sector
Healthcare
Industry
Biotechnology
Exchange
Shanghai Stock Exchange
Capitalization
4 034 978 216 CNY
Yield for 12 month
-37.82 %
1Y
3Y
5Y
10Y
15Y
603590
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The company offers agkistrodon acutus hemocoagulase under Suling trade name, a single-component hemocoagulase clinical hemostatic drug for surgical operations. It is also involved in the development of drug candidates, including CX1026 for the treatment of lung, liver, kidney, colon, and skin T lymphocyte cancer; CX1003, which is in phase 1 trial for the treatment of solid tumors/preferably rare tumors; ZY5301 that is in phase 3 clinical trials for the treatment of chronic pelvic pain in sequelae of pelvic inflammatory disease; KC-B173 for bleeding and prevention of bleeding during surgical or invasive procedures; and KC1036, which is in phase 2 clinical trial for the treatment of solid tumors. The company was founded in 2003 and is headquartered in Beijing, China. Address: No. 11, Xingsheng South Road, Beijing, China
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
322.02 CNYP/E ratio
34.4658Dividend Yield
–Current Year
+922 155 078 CNY
Last Year
+868 745 085 CNY
Current Quarter
+206 267 717 CNY
Last Quarter
+199 700 702 CNY
Current Year
+820 870 323 CNY
Last Year
+742 293 754 CNY
Current Quarter
+186 290 425 CNY
Last Quarter
+177 191 827 CNY
Key Figures 603590
1 year
3 years
5 years
10 years
EBITDA
114 831 320 CNY
Operating Margin TTM
PE Ratio
34.4658
Return On Assets TTM
1.31 %
PEG Ratio
–
Return On Equity TTM
4.28 %
Wall Street Target Price
322.02 CNY
Revenue TTM
848 257 947 CNY
Book Value
20.77 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-10.4 %
Dividend Yield
–
Gross Profit TTM
741 796 893 CNY
Earnings per share
0.73 CNY
Diluted Eps TTM
0.73 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-39.4 %
Profit Margin
13.56 %
Dividend Analytics 603590
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
36 %Dividend History 603590
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
04.07.2024
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
41.15 %
Last Split Date
–
Dividend Date
–
Stock Valuation 603590
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
34.4658
Forward PE
–
Enterprise Value Revenue
4.202
Price Sales TTM
4.7568
Enterprise Value EBITDA
41.9794
Price Book MRQ
1.2418
Financials 603590
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 603590
For 52 weeks
20.12 CNY
42.05 CNY
50 Day MA
22.94 CNY
Shares Short Prior Month
–
200 Day MA
27 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart